Autopsy report · NCT02787083
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
Cause of deathSlow enrollment
“Low enrollment”
Life of this trial
- Registered 3 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Philadelphia Urosurgical Associates
- Sponsor type
- University, hospital or other
- Conditions
- Cystitis, Interstitial
- Interventions
- Mirabegron; Placebo
- Participants
- 9
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.